3-189873035-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000460036.1(TP63):​n.1213G>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.529 in 1,612,994 control chromosomes in the GnomAD database, including 229,603 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.55 ( 23235 hom., cov: 32)
Exomes 𝑓: 0.53 ( 206368 hom. )

Consequence

TP63
ENST00000460036.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.987

Publications

11 publications found
Variant links:
Genes affected
TP63 (HGNC:15979): (tumor protein p63) This gene encodes a member of the p53 family of transcription factors. The functional domains of p53 family proteins include an N-terminal transactivation domain, a central DNA-binding domain and an oligomerization domain. Alternative splicing of this gene and the use of alternative promoters results in multiple transcript variants encoding different isoforms that vary in their functional properties. These isoforms function during skin development and maintenance, adult stem/progenitor cell regulation, heart development and premature aging. Some isoforms have been found to protect the germline by eliminating oocytes or testicular germ cells that have suffered DNA damage. Mutations in this gene are associated with ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3); split-hand/foot malformation 4 (SHFM4); ankyloblepharon-ectodermal defects-cleft lip/palate; ADULT syndrome (acro-dermato-ungual-lacrimal-tooth); limb-mammary syndrome; Rap-Hodgkin syndrome (RHS); and orofacial cleft 8. [provided by RefSeq, Aug 2016]
TP63 Gene-Disease associations (from GenCC):
  • ADULT syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • ankyloblepharon-ectodermal defects-cleft lip/palate syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • limb-mammary syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • Rapp-Hodgkin syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • premature ovarian failure 21
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • split hand-foot malformation 4
    Inheritance: AD Classification: MODERATE Submitted by: Illumina
  • EEC syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • split hand-foot malformation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-189873035-G-C is Benign according to our data. Variant chr3-189873035-G-C is described in ClinVar as Benign. ClinVar VariationId is 259125.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.636 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TP63NM_003722.5 linkc.1349+40G>C intron_variant Intron 10 of 13 ENST00000264731.8 NP_003713.3 Q9H3D4-1A0A0S2Z4N5
TP63NM_001114980.2 linkc.1067+40G>C intron_variant Intron 8 of 11 ENST00000354600.10 NP_001108452.1 Q9H3D4-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TP63ENST00000264731.8 linkc.1349+40G>C intron_variant Intron 10 of 13 1 NM_003722.5 ENSP00000264731.3 Q9H3D4-1
TP63ENST00000354600.10 linkc.1067+40G>C intron_variant Intron 8 of 11 1 NM_001114980.2 ENSP00000346614.5 Q9H3D4-2

Frequencies

GnomAD3 genomes
AF:
0.546
AC:
82935
AN:
151806
Hom.:
23225
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.643
Gnomad AMI
AF:
0.486
Gnomad AMR
AF:
0.468
Gnomad ASJ
AF:
0.457
Gnomad EAS
AF:
0.346
Gnomad SAS
AF:
0.377
Gnomad FIN
AF:
0.484
Gnomad MID
AF:
0.706
Gnomad NFE
AF:
0.546
Gnomad OTH
AF:
0.564
GnomAD2 exomes
AF:
0.487
AC:
121992
AN:
250592
AF XY:
0.487
show subpopulations
Gnomad AFR exome
AF:
0.647
Gnomad AMR exome
AF:
0.386
Gnomad ASJ exome
AF:
0.453
Gnomad EAS exome
AF:
0.359
Gnomad FIN exome
AF:
0.476
Gnomad NFE exome
AF:
0.550
Gnomad OTH exome
AF:
0.516
GnomAD4 exome
AF:
0.527
AC:
770307
AN:
1461070
Hom.:
206368
Cov.:
40
AF XY:
0.523
AC XY:
380473
AN XY:
726882
show subpopulations
African (AFR)
AF:
0.649
AC:
21723
AN:
33464
American (AMR)
AF:
0.396
AC:
17702
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.457
AC:
11930
AN:
26126
East Asian (EAS)
AF:
0.373
AC:
14796
AN:
39688
South Asian (SAS)
AF:
0.375
AC:
32333
AN:
86236
European-Finnish (FIN)
AF:
0.488
AC:
26037
AN:
53402
Middle Eastern (MID)
AF:
0.597
AC:
3440
AN:
5760
European-Non Finnish (NFE)
AF:
0.549
AC:
610620
AN:
1111308
Other (OTH)
AF:
0.526
AC:
31726
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
18578
37156
55733
74311
92889
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17112
34224
51336
68448
85560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.546
AC:
82973
AN:
151924
Hom.:
23235
Cov.:
32
AF XY:
0.536
AC XY:
39799
AN XY:
74242
show subpopulations
African (AFR)
AF:
0.643
AC:
26592
AN:
41384
American (AMR)
AF:
0.467
AC:
7143
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.457
AC:
1584
AN:
3468
East Asian (EAS)
AF:
0.346
AC:
1785
AN:
5162
South Asian (SAS)
AF:
0.378
AC:
1818
AN:
4814
European-Finnish (FIN)
AF:
0.484
AC:
5108
AN:
10560
Middle Eastern (MID)
AF:
0.687
AC:
202
AN:
294
European-Non Finnish (NFE)
AF:
0.546
AC:
37119
AN:
67938
Other (OTH)
AF:
0.558
AC:
1179
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1885
3770
5655
7540
9425
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
706
1412
2118
2824
3530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.445
Hom.:
2119
Bravo
AF:
0.554
Asia WGS
AF:
0.350
AC:
1223
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
4.1
DANN
Benign
0.48
PhyloP100
0.99
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9840359; hg19: chr3-189590824; COSMIC: COSV53199343; API